☆ 4.7 Meeting Abstract

A phase 1 study of EPZ-6438 (E7438), an Enhancer of Zeste-Homolog 2 (EZH2) inhibitor: Preliminary activity in INI1-negative tumors

EUROPEAN JOURNAL OF CANCER (2015)

Journal

EUROPEAN JOURNAL OF CANCER

Volume 51, Issue -, Pages S54-S55

Publisher

ELSEVIER SCI LTD

DOI: 10.1016/S0959-8049(16)30168-X

Keywords

-

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.